Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin 53226
2 studies enrolling now · 43 studies all time
What they study most
Acute Biphenotypic Leukemia (ABL), Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia (AML), Acute Myeloid Leukemia, Acute Pain, Acute Undifferentiated Leukemia (AUL), Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Atrial Fibrillation, Benzodiazepine Refractory Status Epilepticus, Bleeding
Studies at this site
- Study of EV for Recurrent Endometrial Carcinoma — Recruiting now
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — Recruiting now
- Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
- SIMPLAAFY Clinical Trial — Running, not enrolling
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
- Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
- Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
- HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide — Completed
- Impact of Acetazolamide in Reducing Referred Postoperative Pain — Completed
- The Effect of Higher Protein Dosing in Critically Ill Patients — Completed
- A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
- Established Status Epilepticus Treatment Trial — Completed
- Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab — Completed
- CTSI-iPad for Vented Patient Communication — Completed
- Clinical Translational Science Institute (CTSI) Brain HQ Modules vs. Active Controls for Elderly Survivors of ICU — Stopped early
- Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes — Completed
- A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
- Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
- Study of Procoagulation Markers in Stroke Patients — Completed
- Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT — Stopped early
- Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients — Completed
- A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed
- Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis — Stopped early
- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
- Ketamine in Colorectal Surgery — Withdrawn before enrolling
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
- Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer — Completed
- VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial — Completed
- Genetic Study of Young Patients With Colorectal Cancer — Completed
- Optimal Platelet Dose Strategy for Management of Thrombocytopenia — Completed
- Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient — Completed
- Red Cell Storage Duration Study — Completed
- Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) — Completed
- Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) — Stopped early
- Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C — Completed
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma — Status unconfirmed
- Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma — Withdrawn before enrolling
- Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) — Stopped early
- Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) — Stopped early
- Belatacept in Liver Transplant Recipients — Stopped early
- Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed